XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
  Dermatitis
  Pemphigus
  Psoriasis
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Dermatology Channel
subscribe to Dermatology newsletter

Latest Research : Dermatology

   DISCUSS   |   EMAIL   |   PRINT
Imiquimod cream reduces fine lines and wrinkles
Mar 6, 2006, 17:29, Reviewed by: Dr. Priya Saxena

"We initiated this study after anecdotal finding that some AK patients treated with Aldara Cream reported cosmetic improvements to their skin. Further exploration of the cosmetic uses for Aldara Cream is clearly warranted."

 
Results from a new study show that Aldara (imiquimod) Cream, 5%, a topical skin cancer treatment, improved the structure and appearance of prematurely aged skin, including fine lines, wrinkles, dyspigmentations and texture. The findings, from researchers at S.K.I.N. Incorporated, a dermatology research facility, are presented as a poster this weekend at the 64th Annual Meeting of the American Academy of Dermatology in San Francisco.

Aldara Cream is an immune response modifier used to treat precancerous skin lesions called actinic keratoses (AK) as well as superficial basal cell carcinoma (sBCC), a nonmelanoma skin cancer. It works by stimulating the body's immune system. AK and sBCC are the result of a lifetime of exposure to ultraviolet rays of the sun. Long-term exposure to the ultraviolet rays of the sun can also cause structural and cosmetic damage to the skin commonly referred to as photodamage. Photodamaged skin is characterized by fine lines and wrinkles, roughness, dryness, lack of firmness and irregular pigmentation.

"Our results indicate that Aldara Cream may offer patients cosmetic benefits in addition to its important therapeutic role in treating precancerous and cancerous skin lesions," said Albert Kligman, MD, PhD, Professor Emeritus of Dermatology at the University of Pennsylvania and lead investigator in this study. "We initiated this study after anecdotal finding that some AK patients treated with Aldara Cream reported cosmetic improvements to their skin. Further exploration of the cosmetic uses for Aldara Cream is clearly warranted."

The open-label study included ten healthy females with visible signs of photoaging. Volunteers received Aldara Cream five times per week for four weeks. At predetermined intervals, the subjects were evaluated for both visible and microscopic-level changes to the underlying skin structures.

According to the results of this small study, treatment with Aldara Cream corrected the structural changes associated with photodamage caused by sun exposure. Additionally, use of Aldara visibly reduced fine lines and wrinkles, improved skin texture and resulted in more uniform skin color. At the end of the study, 80 percent of the subjects rated these improvements as "moderate" or "great." According to subjects' assessments, 90 percent expressed strong approval of the cosmetic benefits. The visible improvement in appearance was also documented by histological study of biopsies. Aldara Cream was well tolerated in the study and no volunteers reported irritation with redness, stinging, or discomfort.
 

- 64th Annual Meeting of the American Academy of Dermatology in San Francisco.
 

 
Subscribe to Dermatology Newsletter
E-mail Address:

 

About S.K.I.N. INC. S.K.I.N. INC. is a clinical contract laboratory, which provides state of the art dermatologic services for determining the safety and efficacy of topical drugs, cosmetics, and skin care products. The organization was founded in 1993 by Albert M. Kligman MD, PhD and Tracy Stoudemayer who have worked together for over 30 years doing dermatology research, publishing numerous scientific papers and abstracts, and lecturing at national and international meetings.

Related Dermatology News

Adult beachgoers participating in research study accurately report their sun habits
Psoriasis increases risk for heart attack
How do you use your sunscreen?
Skin Cells Found to Use a Coordinate System to Deduct their Positional Identity
UV-A therapy more effective than narrowband UV-B therapy in chronic plaque psoriasis
Distress due to eczema very worrying
Glucosamine can stop formation of new age spots
Low-dose Arsenic in drinking water increases risk of premalignant skin lesions
Atorvastatin may increase new blood vessel formation
Ineffective skin barrier may trigger immune reaction, illness


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us